Free Trial
NASDAQ:TLSA

Tiziana Life Sciences (TLSA) Stock Price, News & Analysis

Tiziana Life Sciences logo
$1.86 +0.12 (+6.90%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.89 +0.03 (+1.61%)
As of 05:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Tiziana Life Sciences Stock (NASDAQ:TLSA)

Key Stats

Today's Range
$1.71
$1.86
50-Day Range
$1.33
$1.86
52-Week Range
$0.63
$1.91
Volume
370,620 shs
Average Volume
217,871 shs
Market Capitalization
$217.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Tiziana Life Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
24th Percentile Overall Score

TLSA MarketRank™: 

Tiziana Life Sciences scored higher than 24% of companies evaluated by MarketBeat, and ranked 844th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Tiziana Life Sciences.

  • Percentage of Shares Shorted

    0.75% of the float of Tiziana Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Tiziana Life Sciences has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tiziana Life Sciences has recently decreased by 20.60%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Tiziana Life Sciences does not currently pay a dividend.

  • Dividend Growth

    Tiziana Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.75% of the float of Tiziana Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Tiziana Life Sciences has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Tiziana Life Sciences has recently decreased by 20.60%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Tiziana Life Sciences has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.09 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Tiziana Life Sciences this week, compared to 1 article on an average week.
  • Search Interest

    7 people have searched for TLSA on MarketBeat in the last 30 days. This is an increase of 133% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Tiziana Life Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.82% of the stock of Tiziana Life Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Tiziana Life Sciences' insider trading history.
Receive TLSA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tiziana Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

TLSA Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Tiziana Life Sciences Ltd (TLSA) - Yahoo Finance
See More Headlines

TLSA Stock Analysis - Frequently Asked Questions

Tiziana Life Sciences' stock was trading at $0.6962 at the start of the year. Since then, TLSA shares have increased by 167.2% and is now trading at $1.86.

Tiziana Life Sciences (TLSA) raised $10 million in an initial public offering (IPO) on the week of November 19th 2018. The company issued 1,000,000 shares at $9.90 per share. Laidlaw & Company (UK) Ltd. served as the underwriter for the IPO.

Shares of TLSA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tiziana Life Sciences investors own include NIO (NIO), Advanced Micro Devices (AMD), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Meta Platforms (META), Inovio Pharmaceuticals (INO) and Pfizer (PFE).

Company Calendar

Today
7/28/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TLSA
CIK
1723069
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.02
Quick Ratio
1.02

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.04 per share
Price / Book
46.50

Miscellaneous

Outstanding Shares
116,850,000
Free Float
70,319,000
Market Cap
$217.34 million
Optionable
Optionable
Beta
-0.05
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:TLSA) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners